TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Race Oncology Ltd. ( (AU:RAC) ).
Race Oncology Ltd has announced the quotation of 243,710 fully paid ordinary securities on the Australian Securities Exchange (ASX) as of November 20, 2025. This move is part of the company’s strategy to enhance its financial flexibility and support its ongoing cancer research and development initiatives, potentially strengthening its market position and offering new opportunities for stakeholders.
More about Race Oncology Ltd.
Race Oncology Ltd is a company operating in the biotechnology industry, focusing on the development and commercialization of cancer therapies. The company is primarily engaged in researching and bringing to market innovative treatments for various types of cancer, with a strong emphasis on improving patient outcomes.
Average Trading Volume: 536,785
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$611.2M
See more data about RAC stock on TipRanks’ Stock Analysis page.